Medical and surgical management of obesity and diabetes: what's new?

Ammori, B J; Skarulis, M C; Soran, H; Syed, A A; Eledrisi, M; Malik, R A

Ammori, B J; Skarulis, M C; Soran, H; Syed, A A; Eledrisi, M; Malik, R A.

Affiliation

Ammori BJ; Department of Surgery, King Hussein Cancer Centre, Amman, Jordan.
Skarulis MC; National Obesity Treatment Centre, Hamad Medical Corporation, Doha, Qatar.
Soran H; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Syed AA; Department of Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
Eledrisi M; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Malik RA; Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.

Diabet Med ; 37(2): 203-210, 2020 02.

Article in En | MEDLINE | ID: mdl-31850536

Subject(s)

Anti-Obesity Agents/therapeutic use; Bariatric Surgery/methods; Diabetes Mellitus, Type 2/therapy; Hypoglycemic Agents/therapeutic use; Obesity/therapy; Diabetes Complications/etiology; Diabetes Mellitus, Type 1/complications; Diabetes Mellitus, Type 2/complications; Humans; Obesity/complications; Obesity Management

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Diabetes Mellitus, Type 2 / Bariatric Surgery / Hypoglycemic Agents / Obesity Type of study: Etiology_studies Limits: Humans Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2020 Type: Article Affiliation country: Jordan

Fulltext

XML

PubMed Links

Search on Google